Evidence map›Paper›PMID 42353669›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Antimicrobial Resistance and Genomic Characterization of Four

Amani T Alsufyani, Ashwaq Alhamed, Norah M Alotaibi, Elaf Alshdokhi, Manal Almusa, Saleh Alaqeel, Hatim Almutairi, James J Davis, Fahad Alreshoodi, Abdulrhman Alsawji and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amani T AlsufyaniSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Ashwaq AlhamedSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Norah M AlotaibiSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Elaf AlshdokhiSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Manal AlmusaSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Saleh AlaqeelSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Hatim AlmutairiSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
James J DavisConsortium for Advanced Science and Engineering, University of Chicago, Chicago, IL 60637, USA.
Fahad AlreshoodiSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Abdulrhman AlsawjiInfectious Disease Research Department, King Abdullah International Medical Research Center, Riyadh 14611, Saudi Arabia.ORCID 0000-0003-1713-9335
Majed F AlghoribiInfectious Disease Research Department, King Abdullah International Medical Research Center, Riyadh 14611, Saudi Arabia.
Sulaiman M AlajelSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.
Lenah E MukhtarSaudi Food and Drug Authority (SFDA), Riyadh 11671, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistancemcr-1 geneSalmonella entericawhole genome sequencing

Identifiers

PMID42353669
PMCPMC13295951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.